Dr. Steven Wexner was recently named chief medical officer for Regentys, a regenerative medicine company specializing in the treatment of ulcerative colitis (UC).
With a long tenure at Cleveland Clinic Florida, Wexner directs its digestive disease center and chairs its colorectal surgery department, according to a company release. Previously he served in several chief executive capacities for the clinic, has won numerous industry accolades and awards and has sat on several boards.
As the nation’s first surgeon to publish work on the colonic J-pouch for rectal cancer, Wexner also advanced improvements in laparoscopy, the release said.
He earned his doctorate degree from the Cornell University medical school, served a general surgery residency at Roosevelt Hospital and completed a fellowship in colorectal surgery at the University of Minnesota Medical School.
"We are excited to have Dr. Wexner join the team,” Brian Andersen, Regentys chief business officer, said in the release. “We believe that our patented drug-free, non-surgical regenerative medicine technology, ECMH, will offer a new and better approach for the treatment of ulcerative colitis. Dr. Wexner's colorectal surgery expertise will allow us to quickly evaluate ECMH in a number of exploratory gastrointestinal surgical procedures."
Regentys was formerly known as Asana Medical Inc., according to the release.